Flinders University introduces a novel debondable polymer adhesive, ideal for press-on or glue-on nails, that depolymerizes with heat. This adhesive also possesses antifungal properties, potentially offering therapeutic benefits in cosmetic applications.
Flinders University has developed an innovative debondable polymer adhesive specifically designed for cosmetic applications, such as press-on or glue-on nails. This adhesive forms a strong bond with materials like plastic and glass, which can last for weeks. It offers the unique ability to depolymerize back to its original building blocks upon the application of gentle heat, allowing for easy removal at home using simple tools like a hair dryer. Additionally, this polymer exhibits antifungal properties, presenting an opportunity to create glue-on nails with therapeutic benefits.
Key features:
Currently at Technology Readiness Level 3, this adhesive technology is in the early stages of testing, with plans to refine adhesive formulations and validate toxicity. Future steps include testing bonding on surfaces mimicking fingernails and establishing debonding protocols. The most promising formulations will be evaluated further on human subjects by a sponsor.
Flinders University is a comprehensive public research university based in Adelaide with a growing footprint across South Australia. Its Tonsley campus sits inside the Tonsley Innovation District, placing researchers alongside industry, government, and startups in facilities designed for co-development and demonstration. The health and medical precinct integrates the university with Flinders Medical Centre and a new Health & Medical Research Building, enabling rapid clinical collaboration and translation. Research is supported by competitive funding from the Australian Research Council, the National Health and Medical Research Council, and the Medical Research Future Fund. A dedicated research partnerships and commercialisation team and an active entrepreneurship institute help industry engage, manage IP, and launch new ventures.